Thalidomide-O-amido-C6-NH2 (hydrochloride)
Thalidomide-O-amido-C6-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs[1].
Product Specifications
CAS Number
[2376990-31-5]
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/thalidomide-o-amido-c6-nh2-hydrochloride.html
Purity
99.32
Solubility
10 mM in DMSO
Smiles
O=C(COC1=CC=CC(C(N2C(C(N3)=O)CCC3=O)=O)=C1C2=O)NCCCCCCN.Cl
Molecular Formula
C21H27ClN4O6
Molecular Weight
466.92
Precautions
H315, H319, H320
References & Citations
[1]Bradner J, et al. Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses. WO 2017024318 A1
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cereblon
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items